These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16804389)

  • 1. Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis.
    Picco MF; Krishna M; Cangemi JR; Shelton D
    Inflamm Bowel Dis; 2006 Jul; 12(7):537-42. PubMed ID: 16804389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment.
    Bresci G; Parisi G; Capria A
    Colorectal Dis; 2008 Oct; 10(8):814-7. PubMed ID: 18834420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
    Lichtenstein GR; Gordon GL; Zakko S; Murthy U; Sedghi S; Pruitt R; Barrett AC; Bortey E; Paterson C; Forbes WP
    Dig Dis Sci; 2016 Jan; 61(1):221-9. PubMed ID: 26563167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of clinical patterns in ulcerative colitis: a long-term follow-up.
    Bresci G; Parisi G; Gambardella L; Banti S; Bertoni M; Rindi G; Capria A
    Int J Clin Pharmacol Res; 1997; 17(1):17-22. PubMed ID: 9403349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.
    Lang A; Salomon N; Wu JC; Kopylov U; Lahat A; Har-Noy O; Ching JY; Cheong PK; Avidan B; Gamus D; Kaimakliotis I; Eliakim R; Ng SC; Ben-Horin S
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1444-9.e1. PubMed ID: 25724700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study.
    Meucci G; Fasoli R; Saibeni S; Valpiani D; Gullotta R; Colombo E; D'Incà R; Terpin M; Lombardi G;
    Inflamm Bowel Dis; 2012 Jun; 18(6):1006-10. PubMed ID: 21830282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
    Bajpai M; Seril DN; Van Gurp J; Geng X; Alvarez J; Minacapelli CD; Gorin S; Das KK; Poplin E; Cheng J; Amenta PS; Das KM
    Dig Dis Sci; 2019 Mar; 64(3):740-750. PubMed ID: 30478770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
    Cohen RD; Woseth DM; Thisted RA; Hanauer SB
    Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and course of ulcerative colitis diagnosed in asymptomatic subjects.
    Park SK; Ye BD; Yang SK; Kim SO; Kim J; Kim JW; Park SH; Yang DH; Jung KW; Kim KJ; Byeon JS; Myung SJ; Kim JH
    J Crohns Colitis; 2014 Oct; 8(10):1254-60. PubMed ID: 24662395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study.
    Yarlas A; D'Haens G; Willian MK; Teynor M
    Inflamm Bowel Dis; 2018 Jan; 24(2):450-463. PubMed ID: 29361097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard treatment of ulcerative colitis.
    Gionchetti P; Rizzello F; Habal F; Morselli C; Amadini C; Romagnoli R; Campieri M
    Dig Dis; 2003; 21(2):157-67. PubMed ID: 14571113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left-sided ulcerative colitis.
    Haghighi DB; Lashner BA
    Gastroenterol Clin North Am; 2004 Jun; 33(2):271-84, ix. PubMed ID: 15177538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis.
    Pica R; Cassieri C; Cocco A; Zippi M; Marcheggiano A; De Nitto D; Avallone EV; Crispino P; Occhigrossi G; Paoluzi P
    Dig Liver Dis; 2015 Nov; 47(11):933-7. PubMed ID: 26391602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once daily vs multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis.
    Li W; Zhang ZM; Jiang XL
    Colorectal Dis; 2016 Jul; 18(7):O214-23. PubMed ID: 27214762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of ulcerative colitis].
    Rammert Ch; Kullak-Ublick GA
    Ther Umsch; 2003 Mar; 60(3):145-50. PubMed ID: 12693317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis.
    Cortot A; Maetz D; Degoutte E; Delette O; Meunier P; Tan G; Cazals JB; Dewit O; Hebuterne X; Beorchia S; Grunberg B; Leprince E; D'Haens G; Forestier S; Idier I; Lémann M
    Am J Gastroenterol; 2008 Dec; 103(12):3106-14. PubMed ID: 19086960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.
    Sandborn WJ; Korzenik J; Lashner B; Leighton JA; Mahadevan U; Marion JF; Safdi M; Sninsky CA; Patel RM; Friedenberg KA; Dunnmon P; Ramsey D; Kane S
    Gastroenterology; 2010 Apr; 138(4):1286-96, 1296.e1-3. PubMed ID: 20064514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical therapy is underused in patients with ulcerative colitis.
    Seibold F; Fournier N; Beglinger C; Mottet C; Pittet V; Rogler G;
    J Crohns Colitis; 2014 Jan; 8(1):56-63. PubMed ID: 23566922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.